Use of cast immobilisation versus removable brace in adults with an ankle fracture: multicentre randomised controlled trial

脚踝 医学 撑杆 随机对照试验 物理疗法 置信区间 外科 机械工程 内科学 工程类
作者
Rebecca Kearney,Rebecca McKeown,Helen Parsons,Aminul Haque,Nick Parsons,Henry Nwankwo,James Mason,Martin Underwood,Anthony C. Redmond,Jaclyn Brown,Siobhan Kefford,Matthew L. Costa
标识
DOI:10.1136/bmj.n1506
摘要

Abstract Objectives To assess function, quality of life, resource use, and complications in adults treated with plaster cast immobilisation versus a removable brace for ankle fracture. Design Multicentre randomised controlled trial. Setting 20 trauma units in the UK National Health Service. Participants 669 adults aged 18 years and older with an acute ankle fracture suitable for cast immobilisation: 334 were randomised to a plaster cast and 335 to a removable brace. Interventions A below the knee cast was applied and ankle range of movement exercises started on cast removal. The removable brace was fitted, and ankle range of movement exercises were started immediately. Main outcome measures Primary outcome was the Olerud Molander ankle score at 16 weeks, analysed by intention to treat. Secondary outcomes were Manchester-Oxford foot questionnaire, disability rating index, quality of life, and complications at 6, 10, and 16 weeks. Results The mean age of participants was 46 years (SD 17 years) and 381 (57%) were women. 502 (75%) participants completed the study. No statistically significant difference was found in the Olerud Molander ankle score between the cast and removable brace groups at 16 weeks (favours brace: 1.8, 95% confidence interval −2.0 to 5.6). No clinically significant differences were found in the Olerud Molander ankle scores at other time points, in the secondary unadjusted, imputed, or per protocol analyses. Conclusions Traditional plaster casting was not found to be superior to functional bracing in adults with an ankle fracture. No statistically difference was found in the Olerud Molander ankle score between the trial arms at 16 weeks. Trial registration ISRCTN registry ISRCTN15537280 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ddffgz完成签到,获得积分20
刚刚
醉熏的灵完成签到 ,获得积分10
刚刚
Jim完成签到,获得积分10
刚刚
houchengru发布了新的文献求助10
1秒前
桐桐应助刘YF采纳,获得10
2秒前
3秒前
ppppp完成签到,获得积分10
4秒前
是然宝啊完成签到,获得积分10
5秒前
鄂百川发布了新的文献求助10
6秒前
自然紫山完成签到,获得积分10
7秒前
维尼发布了新的文献求助10
8秒前
Lowman完成签到,获得积分10
9秒前
wanci应助houchengru采纳,获得50
9秒前
苏卿应助迅速的鹤采纳,获得10
10秒前
kevindm完成签到,获得积分10
10秒前
mjl完成签到,获得积分20
10秒前
JM完成签到,获得积分10
11秒前
老实黄蜂应助Agoni采纳,获得10
12秒前
12秒前
科研通AI2S应助闪闪的山槐采纳,获得10
14秒前
努力发一区完成签到 ,获得积分10
14秒前
充电宝应助小于采纳,获得10
15秒前
饱满的海秋完成签到,获得积分10
15秒前
一丢丢完成签到,获得积分10
15秒前
失眠的煎饼完成签到,获得积分20
15秒前
青耕完成签到 ,获得积分10
16秒前
orixero应助yangxin614采纳,获得10
16秒前
医痞子发布了新的文献求助10
17秒前
慕青应助小酒窝采纳,获得10
17秒前
科研通AI2S应助小鱼采纳,获得10
19秒前
19秒前
19秒前
科研完成签到,获得积分10
20秒前
丘比特应助勇往直前采纳,获得10
20秒前
科研通AI2S应助Agoni采纳,获得10
20秒前
华仔应助ddffgz采纳,获得10
21秒前
受伤凌蝶完成签到,获得积分10
22秒前
Maneuvers完成签到,获得积分10
22秒前
23秒前
23秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3156020
求助须知:如何正确求助?哪些是违规求助? 2807409
关于积分的说明 7872961
捐赠科研通 2465760
什么是DOI,文献DOI怎么找? 1312375
科研通“疑难数据库(出版商)”最低求助积分说明 630083
版权声明 601905